Control of blood pressure in chronic kidney disease: how low to go?

Area of Science:

• Nephrology
• Cardiology
• Hypertension Management

Background:

• Blood pressure (BP) management is vital for slowing chronic kidney disease (CKD) progression and preventing cardiovascular disease (CVD).
• Current hypertension guidelines for CKD patients recommend a target BP <130/80 mm Hg, but lack a defined lower limit.
• Emerging evidence from randomized controlled trials (RCTs) in CKD populations questions the benefits of overly aggressive BP reduction.

Purpose of the Study:

• To review key RCTs investigating optimal target BP levels in patients with CKD.
• To discuss evidence-based, reasonable BP targets for CKD management.
• To identify future research directions in optimizing BP control for CKD patients.

Main Methods:

• Comprehensive literature review of major randomized controlled trials (RCTs) focused on BP targets in CKD.
• Analysis of trial data to evaluate the efficacy and safety of different BP lowering strategies.
• Synthesis of evidence to inform recommendations for target BP levels.

Main Results:

• Recent RCTs indicate that intensive BP lowering may not confer additional benefits for the majority of CKD patients.
• The optimal lower limit for BP targets in CKD remains unclear and may vary among patient subgroups.
• Evidence suggests a potential plateau effect where further BP reduction yields diminishing returns.

Conclusions:

• The current <130/80 mm Hg guideline may require refinement, particularly regarding lower BP thresholds in CKD.
• Personalized BP targets, considering individual patient factors and risk profiles, are likely necessary.
• Further research is essential to establish precise, evidence-based BP targets for diverse CKD populations.